Intracellular Delivery III: Market Entry Barriers of Nanomedicines: 8 (Fundamental Biomedical Technologies, 8) - Image 1

£109.79

Springer Intracellular Delivery III: Market Entry Barriers of Nanomedicines: 8 (Fundamental Biomedical Technologies, 8)

Name: Intracellular Delivery III: Market Entry Barriers of Nanomedicines: 8 (Fundamental Biomedical Technologies, 8)
Brand: Springer
Price: 109.79 GBP
Availability: InStock

General Medical Issues

This is the usual price. Wait for it to drop, or tell us your number.

£110 today · usual range £0–£0 · best ever £103

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 632 days • 632 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 632 days • 9 price levels

Days at Price

Current Price

Price Analysis

Most common price: £106 (206 days, 32.6%)

Price range: £103 - £120

Price levels: 9 different prices over 632 days

Description

A critical review is attempted to assess the status of nanomedicine entry onto the market. The emergence of new potential therapeutic entities such as DNA and RNA fragments requires that these new “drugs” will need to be delivered in a cell-and organelle-specific manner. Although efforts have been made over the last 50 years or so to develop such delivery technology, no effective and above all clinically approved protocol for cell-specific drug delivery in humans exists as yet. Various particles, macromolecules, liposomes and most recently “nanomaterials” have been said to “show promise” but none of these promises have so far been “reduced” to human clinical practice. The focus of this volume is on cancer indication since the majority of published research relates to this application; within that, we focus on solid tumors (solid malignancies). Our aim is critically to evaluate whether nanomaterials, both non-targeted and targeted to specific cells, could be of therapeutic benefit in clinical practice. The emphasis of this volume will be on pharmacokinetics (PK) and pharmacodynamics (PD) in animal and human studies. Apart from the case of exquisitely specific antibody-based drugs, the development of target-specific drug–carrier delivery systems has not yet been broadly successful at the clinical level. It can be argued that drugs generated using the conventional means of drug development (i.e., relying on facile biodistribution and activity after (preferably) oral administration) are not suitable for a target-specific delivery and would not benefit from such delivery even when a seemingly perfect delivery system is available. Therefore, successful development of site-selective drug delivery systems will need to include not only the development of suitable carriers, but also the development of drug entities that meet the required PK/PD profile.

Product Specifications

Brand: Springer
Format: Hardcover
ASIN: 331943523X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 23 December 2016
Listed Since: 23 June 2016

Barcode

No barcode data available

Springer Intracellular Delivery III: Market Entry Barriers of Nanomedicines: 8 (Fundamental Biomedical Technologies, 8)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Intracellular Delivery III: Market Entry Barriers of Nanomedicines: 8 (Fundamental Biomedical Technologies)

Nanomedicine in Drug Delivery

Nanomedicine in Drug Delivery

Nanomedicine: Fundamentals, Synthesis, and Applications

Biointeractions of Nanomaterials

Nanocarriers for Drug-Targeting Brain Tumors (Micro and Nano Technologies)

Nanotechnology and Drug Delivery, Volume Two: Nano-Engineering Strategies and Nanomedicines against Severe Diseases

Nanotechnology in Modern Animal Biotechnology: Concepts and Applications

Advances in Personalized Nanotherapeutics

Elsevier Nanostructures for Drug Delivery - Medical Textbook

Nanomaterial-Based Drug Delivery Systems: Therapeutic and Theranostic Applications

Nanocarriers for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery (Micro and Nano Technologies)

Mucosal Delivery of Drugs and Biologics in Nanoparticles: 41 (AAPS Advances in the Pharmaceutical Sciences Series, 41)

Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)

Pharmaceutical Nanotechnology: Basic Protocols: 2000 (Methods in Molecular Biology, 2000)

Pharmaceutical Nanotechnology: Basic Protocols: 2000 (Methods in Molecular Biology, 2000)

Nanomedicine for the Treatment of Disease: From Concept to Application

Nanotechnology Principles in Drug Targeting and Diagnosis (Micro and Nano Technologies)

Drug Delivery with Targeted Nanoparticles: In Vitro and In Vivo Evaluation Methods

Targeted Nanomedicine for Breast Cancer Therapy

Nanoparticles in Life Sciences and Biomedicine - Taylor & Francis

Engineered Nanoparticles as Drug Delivery Systems (Emerging Materials and Technologies)

Nanocarriers: Drug Delivery System: An Evidence Based Approach

Nanoscale Materials in Targeted Drug Delivery, Theragnosis and Tissue Regeneration